🚀 VC round data is live in beta, check it out!
Compass Pathways Valuation Multiples
Discover revenue and EBITDA valuation multiples for Compass Pathways and similar public comparables like Talkspace, Teladoc, Sphere, Evolent Health and more.
Compass Pathways Overview
About Compass Pathways
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Founded
2020
HQ
Employees
166
Website
Financials (LTM)
EV
$627M
Compass Pathways Financials
Compass Pathways reported last 12-month revenue of — and negative EBITDA of ($189M).
In the same LTM period, Compass Pathways generated — in gross profit, ($189M) in EBITDA losses, and had net loss of ($270M).
Revenue (LTM)
Compass Pathways P&L
In the most recent fiscal year, Compass Pathways reported revenue of — and EBITDA of ($178M).
Compass Pathways expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | ($189M) | XXX | ($178M) | XXX | XXX | XXX |
| Net Profit | ($270M) | XXX | ($288M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Compass Pathways Stock Performance
Compass Pathways has current market cap of $741M, and enterprise value of $627M.
Market Cap Evolution
Compass Pathways' stock price is $5.75.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $627M | $741M | -18.1% | XXX | XXX | XXX | $-2.23 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCompass Pathways Valuation Multiples
Compass Pathways trades at (3.3x) EV/EBITDA.
EV / Revenue (LTM)
Compass Pathways Financial Valuation Multiples
As of April 9, 2026, Compass Pathways has market cap of $741M and EV of $627M.
Equity research analysts estimate Compass Pathways' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Compass Pathways has a P/E ratio of (2.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $741M | XXX | $741M | XXX | XXX | XXX |
| EV (current) | $627M | XXX | $627M | XXX | XXX | XXX |
| EV/EBITDA | (3.3x) | XXX | (3.5x) | XXX | XXX | XXX |
| EV/EBIT | (3.3x) | XXX | (3.6x) | XXX | XXX | XXX |
| P/E | (2.8x) | XXX | (2.6x) | XXX | XXX | XXX |
| EV/FCF | (3.8x) | XXX | (4.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Compass Pathways Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Compass Pathways Margins & Growth Rates
Compass Pathways' revenue in the last fiscal year grew by —.
Compass Pathways' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.1M for the same period.
Compass Pathways Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | 12% | XXX | 24% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.1M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Compass Pathways Public Comps
See public comps and valuation multiples for other Digital Therapeutics and Mental Health Technology comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Talkspace | XXX | XXX | XXX | XXX | XXX | XXX |
| Teladoc | XXX | XXX | XXX | XXX | XXX | XXX |
| Sphere | XXX | XXX | XXX | XXX | XXX | XXX |
| Evolent Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Cybin | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Compass Pathways M&A Activity
Compass Pathways acquired XXX companies to date.
Last acquisition by Compass Pathways was on XXXXXXXX, XXXXX. Compass Pathways acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Compass Pathways
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCompass Pathways Investment Activity
Compass Pathways invested in XXX companies to date.
Compass Pathways made its latest investment on XXXXXXXX, XXXXX. Compass Pathways invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Compass Pathways
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Compass Pathways
| When was Compass Pathways founded? | Compass Pathways was founded in 2020. |
| Where is Compass Pathways headquartered? | Compass Pathways is headquartered in United Kingdom. |
| How many employees does Compass Pathways have? | As of today, Compass Pathways has over 166 employees. |
| Who is the CEO of Compass Pathways? | Compass Pathways' CEO is Kabir Nath. |
| Is Compass Pathways publicly listed? | Yes, Compass Pathways is a public company listed on Nasdaq. |
| What is the stock symbol of Compass Pathways? | Compass Pathways trades under CMPS ticker. |
| When did Compass Pathways go public? | Compass Pathways went public in 2020. |
| Who are competitors of Compass Pathways? | Compass Pathways main competitors are Talkspace, Teladoc, Sphere, Evolent Health. |
| What is the current market cap of Compass Pathways? | Compass Pathways' current market cap is $741M. |
| Is Compass Pathways profitable? | No, Compass Pathways is not profitable. |
| What is the current EBITDA of Compass Pathways? | Compass Pathways has negative EBITDA and is not profitable. |
| What is the current EV/EBITDA multiple of Compass Pathways? | Current EBITDA multiple of Compass Pathways is (3.3x). |
| What is the current FCF of Compass Pathways? | Compass Pathways' last 12 months FCF is ($167M). |
| What is the current EV/FCF multiple of Compass Pathways? | Current FCF multiple of Compass Pathways is (3.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.